These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 6771467

  • 21. Inhibition of aromatase and NADPH cytochrome c reductase activities in human endometrium by the human placental NADPH cytochrome c reductase antiserum.
    Tseng L, Bellino FL.
    J Steroid Biochem; 1985 Apr; 22(4):555-7. PubMed ID: 3923269
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y, Osawa Y, Coon MJ.
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [Abstract] [Full Text] [Related]

  • 24. Suicide inactivation of androstenedione aromatase in human placenta by fluoroethindrone (10 beta-fluoro-17 alpha-ethynyl-19-nortestosterone).
    Yamamoto T, Yoshiji S, Urabe M, Shiroshita K, Fujii M, Honjo H, Okada H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):849-52. PubMed ID: 3598279
    [Abstract] [Full Text] [Related]

  • 25. Novel method of evaluating biological 19-hydroxylation and aromatization of androgens.
    Miyairi S, Fishman J.
    Biochem Biophys Res Commun; 1983 Dec 16; 117(2):392-8. PubMed ID: 6661234
    [Abstract] [Full Text] [Related]

  • 26. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
    Swinney DC, Watson DM, So OY.
    Arch Biochem Biophys; 1993 Aug 15; 305(1):61-7. PubMed ID: 8342956
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
    Covey DF, Hood WF.
    Mol Pharmacol; 1982 Jan 15; 21(1):173-80. PubMed ID: 7132956
    [No Abstract] [Full Text] [Related]

  • 30. Metabolism of androstenedione by placental microsomes in pregnancy hypertension.
    Hähnel ME, Martin JD, Michael CA, Hähnel R.
    Clin Chim Acta; 1989 Apr 28; 181(1):103-8. PubMed ID: 2721001
    [Abstract] [Full Text] [Related]

  • 31. Aromatization of androstenedione and 16alpha-hydroxyandrostenedione in human placental microsomes. Kinetic analysis of inhibition by the 19-oxygenated and 3-deoxy analogs.
    Numazawa M, Watari Y, Komatsu S, Yamashita K, Nagaoka M.
    Steroids; 2008 Nov 28; 73(12):1262-9. PubMed ID: 18611405
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Androgen and 19-norandrogen aromatization by equine and human placental microsomes.
    Dintinger T, Gaillard JL, Moslemi S, Zwain I, Silberzahn P.
    J Steroid Biochem; 1989 Nov 28; 33(5):949-54. PubMed ID: 2601340
    [Abstract] [Full Text] [Related]

  • 34. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.
    Thompson EA, Siiteri PK.
    J Biol Chem; 1974 Sep 10; 249(17):5364-72. PubMed ID: 4153532
    [No Abstract] [Full Text] [Related]

  • 35. NADPH- and iron-dependent lipid peroxidation inhibit aromatase activity in human placental microsomes.
    Milczarek R, Sokołowska E, Hallmann A, Kaletha K, Klimek J.
    J Steroid Biochem Mol Biol; 2008 Jun 10; 110(3-5):230-5. PubMed ID: 18499441
    [Abstract] [Full Text] [Related]

  • 36. Inhibition studies on the aromatization of androst-4-ene-3,17-dione by human placental microsomal preparations.
    Chakraborty J, Hopkins R, Parke DV.
    Biochem J; 1972 Nov 10; 130(1):19P-20P. PubMed ID: 4144071
    [No Abstract] [Full Text] [Related]

  • 37. Aromatization of delta4-androstene-3,17-dione, 19-hydroxy-delta4-androstene-3,17-dione, and 19-oxo-delta4-androstene-3,17-dione at a common catalytic site in human placental microsomes.
    Kelly WG, Judd D, Stolee A.
    Biochemistry; 1977 Jan 11; 16(1):140-5. PubMed ID: 831774
    [Abstract] [Full Text] [Related]

  • 38. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA, Robinson CH.
    Biochemistry; 1982 May 25; 21(11):2773-8. PubMed ID: 7093221
    [Abstract] [Full Text] [Related]

  • 39. Inactivation of microsomal NADPH-cytochrome c reductase by sulfhydryl-reactive derivatives of menadione.
    Talcott RE, Ketterman A, Giannini DG.
    Biochem Pharmacol; 1984 Aug 15; 33(16):2663-8. PubMed ID: 6431988
    [Abstract] [Full Text] [Related]

  • 40. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives.
    Marsh DA, Brodie HJ, Garrett W, Tsai-Morris CH, Brodie AM.
    J Med Chem; 1985 Jun 15; 28(6):788-95. PubMed ID: 4009601
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.